Clinical Trial

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose this study is to measure the impact of laroprovstat (AZD0780) on the pharmacokinetics (PK) of AZD4954 and the impact of AZD4954 on the PK of laroprovstat in healthy male and female participants.
Protocol Amendment History 2 changes
critical Trial completed 2026-08-05
critical Recruitment opened 2026-04-23
Trial Details
NCT Number NCT07513571
Lead Sponsor AstraZeneca
Conditions Healthy Participants
Enrollment 31 participants
Start Date 2026-04-10
Primary Completion 2026-07-08 (estimated)
Study Completion 2026-07-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-04